Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 9—September 2003

Research

Epidemic and Nonepidemic Multidrug-Resistant Enterococcus faecium

Helen L. Leavis*†, Rob J.L. Willems†, Janetta Top†, Emile Spalburg†, Ellen M. Mascini*, Ad C. Fluit*, Andy Hoepelman*, Albert J. de Neeling†, and Marc J.M. Bonten*Comments to Author 
Author affiliations: *University Medical Center Utrecht, Utrecht, the Netherlands; †National Institute of Public Health and the Environment (RIVM), Bilthoven, the Netherlands

Main Article

Figure 2

Frequencies of the esp gene and ampicillin resistance among vancomycin-susceptible enterococci (VSE) and vancomycin-resistant enterococci (VRE) of different origin. Percentages of esp-positive (solid bars) and ampicillin-resistant (dotted bars) VRE and VSE isolates originating from four different sources have been indicated. Clin-Inf, clinical infectious; Clin-Surv, clinical survey; Comm-Surv, community survey.

Figure 2. Frequencies of the esp gene and ampicillin resistance among vancomycin-susceptible enterococci (VSE) and vancomycin-resistant enterococci (VRE) of different origin. Percentages of esp-positive (solid bars) and ampicillin-resistant (dotted bars) VRE and VSE isolates originating from four different sources have been indicated. Clin-Inf, clinical infectious; Clin-Surv, clinical survey; Comm-Surv, community survey.

Main Article

TOP